SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-126925
Filing Date
2023-04-28
Accepted
2023-04-28 16:08:58
Documents
3
Period of Report
2023-06-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d471445ddef14a.htm DEF 14A 463018
2 GRAPHIC g471445g08u00.jpg GRAPHIC 253646
3 GRAPHIC g471445g09u00.jpg GRAPHIC 161034
  Complete submission text file 0001193125-23-126925.txt   1035008
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39247 | Film No.: 23866096
SIC: 2834 Pharmaceutical Preparations